Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bristol-Myers Squibb Company (BMY)

46.31   -0.54 (-1.15%) 05-20 16:01
Open: 46.38 Pre. Close: 46.85
High: 46.58 Low: 46.1
Volume: 10,777,877 Market Cap: 75750M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 46.628 - 46.882 46.882 - 47.094
Low: 45.472 - 45.795 45.795 - 46.063
Close: 45.794 - 46.286 46.286 - 46.695

Technical analysis

as of: 2019-05-20 4:25:42 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 55.83     One year: 58.18
Support: Support1: 44.54    Support2: 37.06
Resistance: Resistance1: 47.80    Resistance2: 49.81
Pivot: 46.95
Moving Average: MA(5): 46.56     MA(20): 46.60
MA(100): 48.67     MA(250): 53.14
MACD: MACD(12,26): -0.11     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 29.75     %D(3): 34.13
RSI: RSI(14): 45.67
52-week: High: 63.69  Low: 44.30  Change(%): -11.4
Average Vol(K): 3-Month: 1854317  10-Days: 1257298

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BMY has closed above bottom band by 26.7%. Bollinger Bands are 33.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 17 May 2019 23:11:05 Z
Celgene Gets EC Nod for Label Expansion of Revlimid, Imnovid

Fri, 17 May 2019 23:11:01 Z
Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL

Thu, 16 May 2019 20:09:35 Z
Here's Why Mirati Therapeutics Is Surging Today

Wed, 15 May 2019 15:14:12 Z
Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer

Tue, 14 May 2019 16:13:46 Z
Zacks.com featured highlights include: BlackRock, Northrop, Progressive, Interpublic Group and Bristol-Myers

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1635.72
Shares Float (M) 1629.20
% Held by Insiders
% Held by Institutions
Shares Short (K) 77458
Shares Short P. Month (K)

Stock Financials

EPS 3.980
EPS Est. Current Year 3.000
EPS Est. Next Year 3.230
EPS Est. Next Quarter 0.790
Forward EPS 3.720
Book Value (p.s.) 5.060
PEG Ratio 2.14
Profit Margin 23.15
Operating Margin 28.65
Return on Assets (ttm) 15.1
Return on Equity (ttm) 36.7
Qtrly Rev. Growth 14.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 15.10
Operating Cash Flow (M) 6150.00
Levered Free Cash Flow (M) 4210.00

Stock Valuations

P/E 11.63
P/E Growth Ratio -0.01
P/BV 9.15
P/S 5322524160.00
P/CF 12.31

Dividends & Splits

Dividend 3.501
Dividend Yield 0.08
Dividend Pay Date 2019-05-01
Ex-Dividend Date 2019-04-04
Forward Dividend 1.640
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.